These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 361228)

  • 41. Phase II study of azotomycin in sarcomas.
    Chang P; Wiernik PH
    Cancer Treat Rep; 1977 Dec; 61(9):1719-20. PubMed ID: 340036
    [No Abstract]   [Full Text] [Related]  

  • 42. Phase II clinical evaluation of 4'-epi-doxorubicin.
    Hurteloup P; Cappelaere P; Armand JP; Mathé G
    Cancer Treat Rep; 1983 Apr; 67(4):337-41. PubMed ID: 6573956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase II trial of bisantrene in previously treated patients with ovarian carcinoma: a Southwest Oncology Group Study.
    Cowan JD; Surwit EA; Alberts DS; Boutselis JG; Neilan BA
    Cancer Treat Rep; 1986 Mar; 70(3):423-4. PubMed ID: 3955558
    [No Abstract]   [Full Text] [Related]  

  • 44. Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
    Gockerman JP; Silberman H; Bartolucci AA
    Cancer Treat Rep; 1987; 71(7-8):773-4. PubMed ID: 3300970
    [No Abstract]   [Full Text] [Related]  

  • 45. [Carminomycin in drug combination in breast cancer and soft tissue sarcomas].
    Lichinitser MR; Assekritova IV; Gorbunova VA
    Antibiotiki; 1977 Oct; 22(10):940-3. PubMed ID: 411416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase II study of maytansine in advanced sarcomas.
    Edmonson JH; Hahn RG; Creagan ET; O'Connell MJ
    Cancer Treat Rep; 1983 Apr; 67(4):401-2. PubMed ID: 6850657
    [No Abstract]   [Full Text] [Related]  

  • 47. Phase II trial of 4'-epi-doxorubicin in metastatic melanoma.
    Torti FM; Porzig KJ; Gandara DR; Volberding P; Mitchell E; Meyers FJ; Kohler M; Gribble M
    Cancer Treat Rep; 1984 Dec; 68(12):1509-10. PubMed ID: 6595059
    [No Abstract]   [Full Text] [Related]  

  • 48. Phase II study of idarubicin in advanced endometrial carcinoma.
    Hakes TB; Raymond V
    Cancer Treat Rep; 1987 May; 71(5):535-6. PubMed ID: 3471330
    [No Abstract]   [Full Text] [Related]  

  • 49. [Study of the antitumor activity of carminomycin in malignant tumors in children (a preliminary report)].
    Durnov LA; Susuleva NA; Lichinitser MR
    Antibiotiki; 1976 Jul; 21(7):654-7. PubMed ID: 782352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Possibilities of preventing cardiotoxic complications in chemotherapy with carminomycin].
    Labkovskiĭ BM; Danova LA; Gershanovich ML; Kondrat'ev VB
    Antibiotiki; 1978 Sep; 23(9):851-4. PubMed ID: 358915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of malignant tumors with bleomycin--therapeutic application in the field of internal medicine].
    Kimura I; Onoshi T; Takata H; Nishizaki Y; Shirai K
    Naika; 1970 Feb; 25(2):317-28. PubMed ID: 5438417
    [No Abstract]   [Full Text] [Related]  

  • 52. A clinical trial of pyrazofurin in combination with 5-azacytidine in acute adult nonlymphocytic leukemia.
    Van Echo DA; Chiuten DF; Markus S; Wiernik PH
    Cancer Clin Trials; 1981; 4(2):129-33. PubMed ID: 6166406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of disseminated sarcomas of the soft tissues].
    Klimenkov AA; Musatov VK; Karapetian RM
    Vopr Onkol; 1973; 19(7):72-81. PubMed ID: 4359262
    [No Abstract]   [Full Text] [Related]  

  • 54. Ifosfamide and mesna: response and toxicity at standard- and high-dose schedules.
    Antman KH; Elias A; Ryan L
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):68-73. PubMed ID: 2110386
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Abbreviated phase I clinical trial of i.v. mitozolomide.
    Joss RA; Ryssel HJ; Bischoff AK; Goldhirsch A; Brunner KW
    Cancer Treat Rep; 1986 Jun; 70(6):797-8. PubMed ID: 3524827
    [No Abstract]   [Full Text] [Related]  

  • 56. New drugs for the treatment of sarcomas.
    van Oosterom AT; Verweij J
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):909-25. PubMed ID: 7490248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study.
    Bull FE; Von Hoff DD; Balcerzak SP; Stephens RL; Panettiere FJ
    Cancer Treat Rep; 1985 Feb; 69(2):231-3. PubMed ID: 3882233
    [No Abstract]   [Full Text] [Related]  

  • 58. Carboplatin, an active drug in advanced head and neck cancer.
    de Andres Basauri L; Lopez Pousa A; Alba E; Sampedro F
    Cancer Treat Rep; 1986 Oct; 70(10):1173-6. PubMed ID: 3530443
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma.
    Grever MR; Benedetti J; Balcerzak SP; Taylor SA; Miller TP; Dakhil SR
    Invest New Drugs; 1994; 12(3):259-61. PubMed ID: 7534752
    [No Abstract]   [Full Text] [Related]  

  • 60. [1st results of the clinical examination of Adriamycin].
    Obrecht P; Westerhausen M; Simon A
    Dtsch Med Wochenschr; 1971 Feb; 96(9):369-76. PubMed ID: 4925338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.